Skip to content

Medical Cannabis and Breast Cancer

Medical Cannabis and Breast Cancer

October is breast cancer awareness month and we at Arfinn Med would like to reiterate the importance of early screening and regular tests.  According to the American Cancer Society:

“Breast cancer is the most common cancer in American women, except for skin cancers. Currently, the average risk of a woman in the United States developing breast cancer sometime in her life is about 13%. This means there is a 1 in 8 chance she will develop breast cancer. This also means there is a 7 in 8 chance she will never have the disease.”

Though more studies are needed, we wanted to share some current research about medical marijuana and how it can possibly help breast cancer patients.

According to Virginia F. Borges, M.D., MMSc., professor of medicine and director of the Breast Cancer Research Program at the University of Colorado Cancer Center, she finds that cannabis can help improve some of the symptoms associated the breast cancer treatment.

“I’ve mainly seen it used in conjunction with prescription drugs to control pain and other side effects in patients living with metastatic disease,” she said. “It’s rare that a person living with metastatic breast cancer would have only one side effect to manage. So, by adding in medical marijuana, it often allows me to cut back on the number of drugs I prescribe. With a high-quality source for medical marijuana and knowing how it affects an individual, using medical marijuana can put more control back in the hands of my patient. If someone is feeling good, she may only need to take one or two drops per day. If she’s not feeling good, she may need three or four drops per day. Many of the prescription drugs don’t have this flexibility. Any time you can give control back to a person when their living with cancer, it’s a good thing.”

In addition to helping with the side effects of treatment, some research has shown the ability for cannabidiol (CBD) to actually treat breast cancer itself.  A study published in the journal Molecular Cancer Therapeutics found CBD to be very helpful in inhibiting aggressive cancer cells.

“In the study the team led by senior scientist Dr. Sean D. McAllister used CBD to inhibit the activity of the Id-1 gene, believed to be responsible for cancer cells becoming more aggressive and metastatic. “Metastasis is the final and fatal step in the progression of breast cancer,” the authors write. “Currently available therapeutic strategies at this stage of cancer progression are often nonspecific, have only marginal efficacy and are highly toxic.”

Though cannabinoid medicine has been shown to help with some aspects of breast cancer and the resulting treatment side effects, more research is needed to truly understand its role in the recovery of breast cancer patients.  We hope that as the stigma of medical marijuana disappears, research will be easier to conduct.

In the meantime, please get regular screenings and encourage others to do as well!

Resources:

https://www.breastcancer.org/treatment/comp_med/types/medical-marijuana

https://health.usnews.com/health-care/patient-advice/articles/2017-09-05/can-marijuana-help-with-breast-cancer

https://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html

Stories you may be interested in

After 50 Years, U.S. Opens The Door To More Cannabis Crops For Scientists

After more than 50 years, the federal government is lifting a roadblock to cannabis research that scientists and advocates say has hindered rigorous studies of the plant and possible drug development. Since 1968, U.S. researchers have been allowed to use cannabis from only one domestic source: a facility based at the University of Mississippi, through a…
Read More

Three Key Voices in the Medical Marijuana Industry

As medical marijuana programs continue to expand throughout the United States, it is important to recognize some of the key voices throughout the industry that got us here. These individuals range from researches to physicians and even to patients who started their own advocacy group. Keep reading to learn about just three of the many…
Read More

REGISTRATION NOW OPEN: Arfinn Med Medical Cannabis Efficacy Portal for Licensed Medical Professionals

Arfinn Med, the first clinician-based medical professional and patient efficacy portal for medical cannabis treatments, is now open for registrations from licensed medical professionals. The free collaborative portal allows medical professionals to register, share, research and communicate HIPAA-compliant benchmark data for medical cannabis treatments. As a free tool for physicians, Arfinn Med offers a new…
Read More

Cannabis and Seniors

As more and more research comes out regarding the medical benefits of cannabis, it’s important to keep up with new research as it becomes available.  Here at Arfinn Med, we constantly review new studies and look at our own deidentified efficacy data to try to find any additional insights we can relay to our registered…
Read More

New Features

As Arfinn Med has become the leading Electronic Medical Record (EMR) and practice management solution for medical cannabis clinics, we have continued to release new features to help improve clinical workflows and patient care. Our newest feature is a custom intake form builder to help gather pertinent patient information prior to appointments. INTAKE FORM BUILDER…
Read More

Illinois dispensary to allow patients to substitute medical marijuana for opioids prescription

SPRINGFIELD, ILL. (KMOV.com) — Thursday, Illinois will become the first state to launch a revised medical marijuana program. The program allows pain suffers who use opioids to temporarily switch to medical marijuana. Following months of planning, the new initiative will launch at the HCI Alternatives medical cannabis dispensary in Springfield, Illinois. In a press release,…
Read More

Leave a Comment

You must be logged in to post a comment.